Australia's most trusted
source of pharma news
Wednesday, 16 October 2024
Posted 15 October 2024 PM
Samsung Bioepis has been named the Company of the Year across the Asia Pacific region at the 2024 Global Generics & Biosimilars Awards for a third consecutive year while Sandoz scooped the pool, with three awards yet again.
The 11th annual awards night held in Milan, Italy last week and organised by pharmaceutical industry intelligence provider Citeline, recognises the exceptional achievements in the generics and biosimilars industry worldwide.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.